InvestorsHub Logo
Followers 21
Posts 1331
Boards Moderated 1
Alias Born 07/02/2013

Re: None

Tuesday, 08/06/2013 1:02:36 AM

Tuesday, August 06, 2013 1:02:36 AM

Post# of 22684
Temanogrel updates

Temanogrel is an inverse agonist of the serotonin 2A receptor intended for the treatment of thrombotic diseases

http://www.earningsimpact.com/Transcript/82519/ARNA/Arena-Pharmaceuticals%2c-Inc----Q2-2013-Earnings-Call/Page/4